Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.600
-0.100 (-3.70%)
At close: Jun 20, 2025, 4:00 PM
2.699
+0.099 (3.79%)
After-hours: Jun 20, 2025, 7:36 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $50.66 million as of June 20, 2025. Its market cap has decreased by -33.40% in one year.
Market Cap
50.66M
Enterprise Value
28.43M
1-Year Change
-33.40%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $50.66M, a decrease of -18.95%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 52.61M | -24.19% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.13B |
| Johnson & Johnson | 359.59B |
| Novo Nordisk | 333.14B |
| AbbVie | 325.99B |
| UnitedHealth Group | 276.47B |
| Abbott Laboratories | 231.00B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |